raiko

You are browsing the archives of raiko.

Rezulin Class Action Lawsuit

The Kahn Gauthier Law Group is investigating any possible lawsuit against drug manufacturer Pfizer to recover for injuries suffered by users of the now-withdrawn diabetes medication Rezulin (troglitazone). Rezulin was prescribed for type 2, or non-insulin dependent, diabetes patients who had not responded to other therapies. This type of diabetes typically is found in adults.
Rezulin [...]

Propulsid Class Action Lawsuit

On March 23, 2000, the US Food and Drug Administration (FDA) announced that Janssen Pharmaceutica
(a wholly-owned subsidiary of Johnson & Johnson) would cease marketing of cisapride (Propulsid) in the United States as of July 14, 2000. In its announcement, the FDA stated that as of December 31, 1999, use of cisapride has been associated with [...]

Prempro Class Action Lawsuit

The Kahn Gauthier Law Group has commenced an investigation into any possible lawsuit against the manufacturers of Prempro. Federal investigators have made the startling announcement that Wyeth’s drug Prempro, an estrogen-progestin combination that millions of American women take to ease the symptoms of menopause, increases the risk of several serious ailments, including heart attack, stroke, [...]

PPA – Phenylpropanolamine Hydrochloride Class Action Lawsuit

The FDA has issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is an ingredient used in many over-the-counter and prescription cough and cold medications as a decongestant as well as weight loss products.
Studies have reported that taking PPA increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the [...]

Paxil Class Action Lawsuit

On September 27, 2005, the FDA released an alert to healthcare professionals and consumers as GlaxoSmithKline changed the warning label on Paxil (also known as paroxetine) to include the risk of birth defects. The results of a recent study suggests an increased risk of babies born with birth defects, specifically cardiovascular defects or congenital malformations, [...]

Ipod Nano Class Action Lawsuit

Apple Computer is the target of a class action lawsuit that has been launched and claims that the company’s newly released iPod nano scratches too easily. The lawsuit, filed in US District Court in San Jose California, could represent up to 125,000 iPod owners.
The class action lawsuit claims that the iPod Nano is defectively designed [...]

Meridia Class Action Lawsuit

Meridia is the brand name of the popular diet drug sibutramine, and is manufactured by Abbott Laboratories. It is estimated that nine million people worldwide have taken Meridia for the treatment of obesity and to promote weight loss since it was introduced to the market in 1998.
Since Meridia’s introduction to the U.S. market in March [...]

Fen-Phen Class Action Lawsuit

On January 3, 2002, a national settlement, valued at $3.75 billion, of the thousands of lawsuits brought against American Home Products to recover for injuries from taking the now-banned prescription drugs Pondimin (fenfluramine) or Redux (dexfenfluramine), both of which were manufactured by American Home Products, received final judicial approval. The drugs were often used in [...]

Ephedra Class Action Lawsuit

A United States District Court in Miami, Florida, issued an order this week refusing to certify a class action filed by six individuals against Metabolife International, Inc. relating to its over-the-counter dietary supplement Metabolife 356.
In Perez v. Metabolife International, Inc., a lawsuit pending in the United States District Court for the Southern District of Florida, [...]

Depo-Provera Class Action Lawsuit

Women are suing the maker of Depo-Provera birth control claiming that the birth control drug has caused them severe bone loss leading to osteoporosis.  A $700-million class-action lawsuit was been filed against the drug company Pfizer.  Pfizer is an international pharmaceutical conglomerate that also markets the drugs Viagra, Zoloft and Celebrex.  Pfizer has already been [...]